Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries
608, 6th Floor Lingapur Complex, Himayath Nagar
Hyderabad-500 029
India
Phone: +91-40-27803608
Fax: +91-40-27890669
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: VIVOBIOT
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Vivo Bio Tech Ltd is a Contract Research Services Company offering pharma and biotech companies, its skilled services in the area of Custom Research(Biosimilars), Non-Clinical and Clinical Development Services. The company has excellent expertise in Design & Development of Animal models & in providing Preclinical toxicology services. The service portfolio includes: Standard Regulatory Toxicology Battery, Safety Pharmacology & Efficacy Studies.The company offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and antibodies. The company provides BA/BE and Clinical Research (Phase II /Phase III) services. The company has a good network with premier hospitals in India for conduct of clinical trials and also has a panel of 70+ principal investigators of various disciplines.
Towards providing world class infrastructure for the Biopharmaceutical R&D, Vivo Bio is developing a Biotech SEZ (Multi -Company / Multi -Services) in about 11 Hectares located at Pregnapur, Medak Distt., also known as the Genome Valley of A.P. This SEZ is located close to the Biotech Hub (ICICI Knowledge Park, S.P. Biotech Park) with premier Biotech and Pharmaceutical Companies nearby. Multiple Units of Half-Acre or One Acre can be made available for Companies / Research Institutions interested in estabilishing presence in the SEZ.
The initial capacity of builtup space availability is of 125,000 Sq. ft small animal facility (vivarium) and its associated services, of which 75,000 Sq. ft of facility is proposed to start commercial operations by Q3 2009.
The facility is being built in compliance with AAALAC & GLP international specifications. The Company is listed on the Bombay Stock Exchange, India. We wish to collaborate with you for a mutually beneficial association and welcome you for further discussions.
Selected Categories:
Last update of this entry: October 27, 2009
|